A new publication dated October 1, 2026 reports research involving vasoactive intestinal peptide in the context of gut health. The study, titled "Integrated UHPLC-MS/MS and 16S rRNA sequencing reveals that Weiling Decoction alleviates spleen deficiency with dampness pattern diarrhea by modulating intestinal microbiota," appeared in the journal 3 Biotech. The paper describes an integrated analytical approach combining UHPLC-MS/MS with 16S rRNA sequencing to examine intestinal microbiota in the context of a traditional formulation known as Weiling Decoction. This publication is listed under PubMed ID 42719236. The event data indicates this is a newly indexed publication rather than a report of specific findings or outcomes. No results, efficacy data, or safety conclusions are provided beyond the existence and title of this publication. Readers interested in the broader role of vasoactive intestinal peptide in physiological and research contexts can consult the compound overview for additional background information.
Study Links Weiling Decoction, Gut Microbiota, and VIP Pathways
See the full vasoactive intestinal peptide overview
Source: https://pubmed.ncbi.nlm.nih.gov/42719236/